
GSK vs MNKD
$GSK vs $MNKD head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs MNKD: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·Their trends point opposite ways: MNKD is above both its 50- and 200-day averages while GSK is below both.
- ·Neither kept up with the market over the past year: GSK +3.5% and MNKD -20.3%, against the S&P 500 at +8.8%.
- ·The last month has flipped the order: MNKD leads over the month (+30.7% against -4.1%) even though GSK leads over the year.
- ·MNKD has support 4.8% below at $3.78; GSK has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
GSK vs MNKD: the quick read
- ·GSK is the larger company by market cap ($98.26B vs $1.31B).
- ·MNKD has been more active on our scanner (121 vs 73 alerts in 30 days).
- ·MNKD has the smaller float (313.5M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: MNKD is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·Both stay busy on our scanner, 121 and 73 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: GSK is more than 75x the market cap of MNKD, so the same dollar of news moves MNKD far harder.
- ·GSK pays a dividend and MNKD does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching GSK or MNKD? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and MNKD on TheDesperateTrader.
- Is GSK or MNKD the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($98.26B vs $1.31B). MNKD has been more active on our scanner (121 vs 73 alerts in 30 days). MNKD has the smaller float (313.5M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and MNKD?
- The differences that matter: GSK is roughly 75x the size of the other by market cap ($98.26B vs $1.31B); they trade at very different share prices ($47.80 vs $3.98); GSK sits at 13% of its 52-week range against 41% for MNKD; only GSK pays a dividend; our scanner flagged GSK 73 times in the last 30 days against 121 for MNKD. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and MNKD is more active right now?
- Right now GSK is at about 0.5x its normal volume and MNKD is at about 0.6x, so MNKD is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is GSK or MNKD in the stronger trend?
- GSK is below its 50-day average of $49.32 and below its 200-day average of $52.31; MNKD is above its 50-day average of $3.57 and above its 200-day average of $3.61. MNKD leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or MNKD? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GSK and MNKD comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.